You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
McKesson
Baxter
Medtronic
Colorcon

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

Patent: 7,108,663

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,108,663
Title:Method and apparatus for cartilage growth stimulation
Abstract: The invention relates to apparatus and method for ultrasonically stimulating cartilage growth. The apparatus includes at least one ergonomically constructed ultrasonic transducer configured to cooperate with a placement module or strip for placement in proximity to an area where cartilage growth is desired. The apparatus also utilizes a portable, ergonomically constructed main operating unit constructed to fit within a pouch worn by the patient. In operation, at least one ultrasonic transducer positioned in proximity to an osteochondral site is excited for a predetermined period of time. To ensure that at least one ultrasonic transducer is properly positioned, and to insure compliance with a treatment protocol, a safety interlock is provided to prevent inadvertent excitation of the at least one ultrasonic transducer.
Inventor(s): Talish; Roger J. (Hillsborough, NJ), Ryaby; John P. (Essex Falls, NJ), Rose; Emery (Astoria, NY), Winder; Alan A. (Westport, CT), Urgovitch, Sr.; Kenneth (Clifton, NJ)
Assignee: Exogen, Inc. (Piscataway, NJ)
Application Number:10/026,290
Patent Claims:see list of patent claims

Details for Patent 7,108,663

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Vericel Corporation MACI autologous cultured chondrocytes IMPLANT 125603 1 2017-01-11   Start Trial Exogen, Inc. (Piscataway, NJ) 2017-02-06 search
Vericel Corporation MACI autologous cultured chondrocytes IMPLANT 125603 001 2017-01-11   Start Trial Exogen, Inc. (Piscataway, NJ) 2017-02-06 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Harvard Business School
Medtronic
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.